Drug factory · FDA FEI 1818556
Flint Welding Supply Company
2201 Branch Rd, Flint, MI, United States
Problems found, fixed voluntarily at FDA's last inspection, Feb 12, 2015.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
2 drug inspections on record since 2011: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Nitrogen | Makes it | Flint Welding Supply Company | 10412-0095 |
| Oxygen | Makes it | Flint Welding Supply Company | 10412-0001 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 12, 2015 | Problems found, fixed voluntarily | Drug Quality Assurance | 3 |
| Aug 4, 2011 | Problems found, fixed voluntarily | Drug Quality Assurance | 2 |
What inspectors wrote down
From FDA's Form 483 citations: conditions an investigator observed that may violate drug manufacturing rules, as FDA published them.
Feb 12, 2015 inspection
- Calibration - at intervals, written program, remedial action 21 CFR 211.160(b)(4)
The calibration of gauges is not done at suitable intervals in accordance with an established written program. - Lack of written stability program 21 CFR 211.166(a)
There is no written testing program designed to assess the stability characteristics of drug products. - Procedures not in writing, fully followed 21 CFR 211.22(d)
The responsibilities and procedures applicable to the quality control unit are not in writing.
Aug 4, 2011 inspection
- Calibration - at intervals, written program, remedial action 21 CFR 211.160(b)(4)
The calibration of instruments and gauges is not done at suitable intervals in accordance with an established written program. - Written Procedures Not Followed 21 CFR 211.80(a)
Written procedures are not followed for the receipt and approval of drug product containers.
Registered with FDA for: manufacture.